JD Bioscience Inc.
- Biotech or pharma, animal health
JD Bioscience is an innovative South Korean pharma company, specializing in the discovery and development of novel therapeutic compounds for MASH, IBD, Cardiomyopathy, Dravet Syndrome and Cancer. We are seeking global or regional partners for the development of our lead asset GM-60106 for the treatment of MASH. Furthermore we would be delighted to meet with companies interested in collaborative development of IBD,AMD, CKD, Cardiomyopathy, Dravet Syndrome assets along with collaborative research in cancer with our novel ADC linker and payload.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}